2021 Vol.39, N°4 - Suppl.131 - Table of contents
Scleroderma 2021
One year in review
CER14769
2021,39,4,Suppl.131
Pg. 0003-0012
Free to view
One year in review 2021: systemic sclerosis
M. Di Battista, S. Barsotti, M. Orlandi, G. Lepri, V. Codullo, A. Della Rossa, S. Guiducci, F. Del Galdo
DOI: https://doi.org/10.55563/clinexprheumatol/izadb8
M. Di Battista, S. Barsotti, M. Orlandi, G. Lepri, V. Codullo, A. Della Rossa, S. Guiducci, F. Del Galdo
DOI: https://doi.org/10.55563/clinexprheumatol/izadb8
Aetiopathogenesis
CER13954
2021,39,4,Suppl.131
Pg. 0013-0019
Free to view
Thrombin generation potential is enhanced in systemic sclerosis: impact of selected endothelial biomarkers
P. Kuszmiersz, R. Pacholczak-Madej, A. Siwiec, M. Celińska-Lowenhoff, T. Iwaniec, J. Kosałka-Węgiel, L. Zaręba, S. Bazan-Socha, J. Dropiński
DOI: https://doi.org/10.55563/clinexprheumatol/d03dnc
P. Kuszmiersz, R. Pacholczak-Madej, A. Siwiec, M. Celińska-Lowenhoff, T. Iwaniec, J. Kosałka-Węgiel, L. Zaręba, S. Bazan-Socha, J. Dropiński
DOI: https://doi.org/10.55563/clinexprheumatol/d03dnc
CER14270
2021,39,4,Suppl.131
Pg. 0020-0024
Free to view
Regulatory B cell imbalance correlates with Tfh expansion in systemic sclerosis
L. Ricard, F. Malard, S. Riviere, C. Laurent, O. Fain, M. Mohty, B. Gaugler, A. Mekinian
DOI: https://doi.org/10.55563/clinexprheumatol/fq8tm9
L. Ricard, F. Malard, S. Riviere, C. Laurent, O. Fain, M. Mohty, B. Gaugler, A. Mekinian
DOI: https://doi.org/10.55563/clinexprheumatol/fq8tm9
Clinical aspects
CER13426
2021,39,4,Suppl.131
Pg. 0025-0028
Free to view
Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis
M.G. Lazzaroni, C. Campochiaro, E. Bertoldo, G. De Luca, C. Caimmi, A. Tincani, F. Franceschini, P. Airò
DOI: https://doi.org/10.55563/clinexprheumatol/mg0paj
M.G. Lazzaroni, C. Campochiaro, E. Bertoldo, G. De Luca, C. Caimmi, A. Tincani, F. Franceschini, P. Airò
DOI: https://doi.org/10.55563/clinexprheumatol/mg0paj
CER13668
2021,39,4,Suppl.131
Pg. 0029-0033
Free to view
Outcomes of conventionally-treated systemic sclerosis patients eligible for autologous haematopoietic stem cell transplantation
S.T. Panopoulos, M.G. Tektonidou, V.-K. Bournia, K. Laskari, P.P. Sfikakis
DOI: https://doi.org/10.55563/clinexprheumatol/dhn3mb
S.T. Panopoulos, M.G. Tektonidou, V.-K. Bournia, K. Laskari, P.P. Sfikakis
DOI: https://doi.org/10.55563/clinexprheumatol/dhn3mb
CER13998
2021,39,4,Suppl.131
Pg. 0034-0042
Free to view
The Hospital Anxiety and Depression Scale in patients with systemic sclerosis: a psychometric and factor analysis in a monocentric cohort
A. Garaiman, C. Mihai, R. Dobrota, S. Jordan, B. Maurer, J. Flemming, O. Distler, M.O. Becker
DOI: https://doi.org/10.55563/clinexprheumatol/qo1ehz
A. Garaiman, C. Mihai, R. Dobrota, S. Jordan, B. Maurer, J. Flemming, O. Distler, M.O. Becker
DOI: https://doi.org/10.55563/clinexprheumatol/qo1ehz
CER14025
2021,39,4,Suppl.131
Pg. 0043-0051
Free to view
Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA
S. Sankar, M. Habib, S. Jaafar, V. Nagaraja, D. Roofeh, A. Young, S. Huang, D. Khanna
DOI: https://doi.org/10.55563/clinexprheumatol/9ivp9g
S. Sankar, M. Habib, S. Jaafar, V. Nagaraja, D. Roofeh, A. Young, S. Huang, D. Khanna
DOI: https://doi.org/10.55563/clinexprheumatol/9ivp9g
CER14598
2021,39,4,Suppl.131
Pg. 0052-0056
Free to view
Erectile function and connective tissue diseases. Prevalence of erectile dysfunction in German men with systemic sclerosis compared to other connective tissue diseases and healthy subjects
S.M. Krittian, S.J. Saur, A. Schloegl, J. Ritzau, T. Xenitidis, A.-C. Pecher, J.C. Henes
DOI: https://doi.org/10.55563/clinexprheumatol/e9n3n9
S.M. Krittian, S.J. Saur, A. Schloegl, J. Ritzau, T. Xenitidis, A.-C. Pecher, J.C. Henes
DOI: https://doi.org/10.55563/clinexprheumatol/e9n3n9
CER14692
2021,39,4,Suppl.131
Pg. 0057-0065
Free to view
Evaluation of endothelial dysfunction and clinical events in patients with early-stage vasculopathy in limited systemic sclerosis
P. Jud, A. Meinitzer, H. Strohmaier, G. Schwantzer, V. Foris, G. Kovacs, A. Avian, B. Odler, F. Moazedi-Fürst, M. Brodmann, F. Hafner
DOI: https://doi.org/10.55563/clinexprheumatol/243mpp
P. Jud, A. Meinitzer, H. Strohmaier, G. Schwantzer, V. Foris, G. Kovacs, A. Avian, B. Odler, F. Moazedi-Fürst, M. Brodmann, F. Hafner
DOI: https://doi.org/10.55563/clinexprheumatol/243mpp
Diagnosis
CER13455
2021,39,4,Suppl.131
Pg. 0066-0076
Free to view
Insulin-like growth factor binding protein 7 as a candidate biomarker for systemic sclerosis
Y.-M. Yan, J.-N. Zheng, Y. Li, Q.-R. Yang, W.-Q. Shao, Q. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/b9j9fd
Y.-M. Yan, J.-N. Zheng, Y. Li, Q.-R. Yang, W.-Q. Shao, Q. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/b9j9fd
CER14074
2021,39,4,Suppl.131
Pg. 0077-0084
Free to view
Sensitivity to change of joint count composite indices in 72 patients with systemic sclerosis
V. Lóránd, G. Nagy, Z. Bálint, D. Komjáti, T. Minier, G. Kumánovics, N. Farkas, I.H. Tarner, U. Müller-Ladner, L. Czirják, C. Varjú
on behalf of the DeSScipher Consortium and contributing EUSTAR Centres
DOI: https://doi.org/10.55563/clinexprheumatol/cl3bbb
V. Lóránd, G. Nagy, Z. Bálint, D. Komjáti, T. Minier, G. Kumánovics, N. Farkas, I.H. Tarner, U. Müller-Ladner, L. Czirják, C. Varjú
on behalf of the DeSScipher Consortium and contributing EUSTAR Centres
DOI: https://doi.org/10.55563/clinexprheumatol/cl3bbb
CER13610
2021,39,4,Suppl.131
Pg. 0085-0093
Free to view
Diagnostic measures for patients with systemic sclerosis-associated myopathy
R. Baumberger, S. Jordan, O. Distler, P. Baschung Pfister, B. Maurer
DOI: https://doi.org/10.55563/clinexprheumatol/tt4ilu
R. Baumberger, S. Jordan, O. Distler, P. Baschung Pfister, B. Maurer
DOI: https://doi.org/10.55563/clinexprheumatol/tt4ilu
CER13868
2021,39,4,Suppl.131
Pg. 0094-0102
Free to view
Evaluation of cardiopulmonary exercise test in the prediction of disease progression in systemic sclerosis
R.A. Hemelein, I. Lajkó, K. Baráth, J. Varga, G. Ágoston, D. Hulló, M. Bocskai, D. Dobi, Z. Rózsavölgyi, Á. Milassin, A. Varga, A. Somfay, L. Kovács
DOI: https://doi.org/10.55563/clinexprheumatol/tktu8v
R.A. Hemelein, I. Lajkó, K. Baráth, J. Varga, G. Ágoston, D. Hulló, M. Bocskai, D. Dobi, Z. Rózsavölgyi, Á. Milassin, A. Varga, A. Somfay, L. Kovács
DOI: https://doi.org/10.55563/clinexprheumatol/tktu8v
CER14445
2021,39,4,Suppl.131
Pg. 0103-0110
Free to view
The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertension
K. Ninagawa, M. Kato, H. Ohira, S. Tsuneta, H. Iwano, M. Kono, Y. Fujieda, K. Oku, I. Tsujino, T. Atsumi
DOI: https://doi.org/10.55563/clinexprheumatol/c1j9gb
K. Ninagawa, M. Kato, H. Ohira, S. Tsuneta, H. Iwano, M. Kono, Y. Fujieda, K. Oku, I. Tsujino, T. Atsumi
DOI: https://doi.org/10.55563/clinexprheumatol/c1j9gb
CER14683
2021,39,4,Suppl.131
Pg. 0111-0118
Free to view
Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea
J.W. Ha, J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/nkcry1
J.W. Ha, J.Y. Pyo, S.S. Ahn, J.J. Song, Y.-B. Park, S.-W. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/nkcry1
CER14677
2021,39,4,Suppl.131
Pg. 0119-0123
Free to view
Laser speckle contrast analysis is a reliable measure of digital blood perfusion in Black Africans with systemic sclerosis
C. Ickinger, V. Lambrecht, M. Tikly, A. Vanhaecke, M. Cutolo, V. Smith
DOI: https://doi.org/10.55563/clinexprheumatol/vl4ils
C. Ickinger, V. Lambrecht, M. Tikly, A. Vanhaecke, M. Cutolo, V. Smith
DOI: https://doi.org/10.55563/clinexprheumatol/vl4ils
Treatment
CER13926
2021,39,4,Suppl.131
Pg. 0124-0133
Free to view
A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale
R. Spiera, D. Khanna, M. Kuwana, D.E. Furst, T.M. Frech, L. Hummers, W. Stevens, M. Matucci-Cerinic, M. Baron, O. Distler, N. Dgetluck, B.J. Bloom, Q. Dinh, B. White, C.P. Denton
DOI: https://doi.org/10.55563/clinexprheumatol/i80zh7
R. Spiera, D. Khanna, M. Kuwana, D.E. Furst, T.M. Frech, L. Hummers, W. Stevens, M. Matucci-Cerinic, M. Baron, O. Distler, N. Dgetluck, B.J. Bloom, Q. Dinh, B. White, C.P. Denton
DOI: https://doi.org/10.55563/clinexprheumatol/i80zh7
CER14050
2021,39,4,Suppl.131
Pg. 0134-0141
Free to view
The effect of nintedanib versus mycophenolate mofetil in the Fra2 mouse model of systemic sclerosis-associated interstitial lung disease
L. Wollin, T. Trinh-Minh, Y. Zhang, J.H. Distler
DOI: https://doi.org/10.55563/clinexprheumatol/g5mej7
L. Wollin, T. Trinh-Minh, Y. Zhang, J.H. Distler
DOI: https://doi.org/10.55563/clinexprheumatol/g5mej7
CER14124
2021,39,4,Suppl.131
Pg. 0142-0148
Free to view
Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosis
N. Richard, G. Gyger, S. Hoa, S. Proudman, W. Stevens, M. Nikpour, M. Wang, M.E. Schnitzer, M. Baron, M. Hudson
Canadian Scleroderma Research Group (CSRG), Australian Scleroderma Interest Group (ASIG)
DOI: https://doi.org/10.55563/clinexprheumatol/7683pg
N. Richard, G. Gyger, S. Hoa, S. Proudman, W. Stevens, M. Nikpour, M. Wang, M.E. Schnitzer, M. Baron, M. Hudson
Canadian Scleroderma Research Group (CSRG), Australian Scleroderma Interest Group (ASIG)
DOI: https://doi.org/10.55563/clinexprheumatol/7683pg
Paediatric Rheumatology
CER13582
2021,39,4,Suppl.131
Pg. 0149-0156
Free to view
Clinical profile, long-term follow-up and outcome of juvenile systemic scleroderma: 25 years of clinical experience from North-West India
A.K. Jindal, P. Patra, S. Guleria, A. Gupta, S. Bhattad, A. Rawat, D. Suri, V. Pandiarajan, A. Bishnoi, S. Dogra, S. Singh
DOI: https://doi.org/10.55563/clinexprheumatol/7ubxxi
A.K. Jindal, P. Patra, S. Guleria, A. Gupta, S. Bhattad, A. Rawat, D. Suri, V. Pandiarajan, A. Bishnoi, S. Dogra, S. Singh
DOI: https://doi.org/10.55563/clinexprheumatol/7ubxxi
Letters to the Editor
CER13850
2021,39,4,Suppl.131
Pg. 0157-0158
Free to view
Systemic sclerosis and COVID-19: what’s new in the literature
B. Russo, J. Ben Shimol, M. Matucci-Cerinic, C. Bruni
DOI: https://doi.org/10.55563/clinexprheumatol/muidl3
B. Russo, J. Ben Shimol, M. Matucci-Cerinic, C. Bruni
DOI: https://doi.org/10.55563/clinexprheumatol/muidl3
CER14081
2021,39,4,Suppl.131
Pg. 0159
Free to view
Autologous lipotransfer can improve the outcomes of localised scleroderma
B.J. Langridge, F.H. Jeon, A. Almadori, M.F. Griffin, C.P. Denton, P.E. Butler
DOI: https://doi.org/10.55563/clinexprheumatol/uczb6s
B.J. Langridge, F.H. Jeon, A. Almadori, M.F. Griffin, C.P. Denton, P.E. Butler
DOI: https://doi.org/10.55563/clinexprheumatol/uczb6s
CER14077
2021,39,4,Suppl.131
Pg. 0160
Free to view
The COVID-19 pandemic highlighted the importance of telemedicine in the collagen disease of systemic sclerosis
Y. Norimatsu, A. Yoshizaki, T. Fukasawa, S. Ebata, K. Oba, S. Sato
DOI: https://doi.org/10.55563/clinexprheumatol/1ek6am
Y. Norimatsu, A. Yoshizaki, T. Fukasawa, S. Ebata, K. Oba, S. Sato
DOI: https://doi.org/10.55563/clinexprheumatol/1ek6am
CER14523
2021,39,4,Suppl.131
Pg. 0161-0162
Free to view
An unusual lung involvement in scleroderma: lipoid pneumonia
L. Verardi, L. Calandriello, E. De Lorenzis, G. Natalello, L. Gigante, G. Cicchetti, A.R. Larici, E. Gremese, M.A. D'agostino, S.L. Bosello
DOI: https://doi.org/10.55563/clinexprheumatol/8nbxxg
L. Verardi, L. Calandriello, E. De Lorenzis, G. Natalello, L. Gigante, G. Cicchetti, A.R. Larici, E. Gremese, M.A. D'agostino, S.L. Bosello
DOI: https://doi.org/10.55563/clinexprheumatol/8nbxxg
CER14681
2021,39,4,Suppl.131
Pg. 0163-0164
Free to view
Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome
G. Boleto, J.-B. Cren, J. Avouac, Y. Allanore
DOI: https://doi.org/10.55563/clinexprheumatol/gu1ac8
G. Boleto, J.-B. Cren, J. Avouac, Y. Allanore
DOI: https://doi.org/10.55563/clinexprheumatol/gu1ac8
CER14767
2021,39,4,Suppl.131
Pg. 0165-0166
Free to view
COVID-19 vaccine hesitancy in systemic sclerosis
J. Ciaffi, D. Giuggioli, A. Mari, M. D'onghia, A. Spinella, V. Brusi, L. Mancarella, L. Lisi, J. Faranda Cordella, D. Freeman, M.P. Landini, C. Ferri, R. Meliconi, F. Ursini
DOI: https://doi.org/10.55563/clinexprheumatol/vv61xv
J. Ciaffi, D. Giuggioli, A. Mari, M. D'onghia, A. Spinella, V. Brusi, L. Mancarella, L. Lisi, J. Faranda Cordella, D. Freeman, M.P. Landini, C. Ferri, R. Meliconi, F. Ursini
DOI: https://doi.org/10.55563/clinexprheumatol/vv61xv